우진비앤지
2,670KRWMarket close of 10/21 (Wed)
Up +2.69%+70KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)2,725KRWUp +2.06%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 2,590
- High
- 2,670
- Low
- 2,575
- Day range
- Day range low 2,575 high 2,670, open 2,590, close 2,670, previous close 2,600
- Volume
- 1×10K shares
- 25.05 million KRW 0.92× the 20-session average
Market close of 10/21 (Wed)
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range+2.69%+2.69%, 1.6× the usual (20-session average ±1.70%)That day +2.69% · usual ±1.70% · large-move threshold ±3.4%
The other 3 are within the usual range
- Trading value0.9×usual range
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue14.3B KRW
- vs. year ago
- -0.1%
- vs. prior quarter
- +6.1%
- Operating income705.08 million KRW
- vs. year ago
- +66.5%
- vs. prior quarter
- +53.6%
- Operating margin4.9%
- vs. year ago
- +2.0 pp
- vs. prior quarter
- +1.5 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-14Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.